pubmed-article:17404043 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17404043 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:17404043 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
pubmed-article:17404043 | lifeskim:mentions | umls-concept:C0009324 | lld:lifeskim |
pubmed-article:17404043 | lifeskim:mentions | umls-concept:C0028128 | lld:lifeskim |
pubmed-article:17404043 | lifeskim:mentions | umls-concept:C1704256 | lld:lifeskim |
pubmed-article:17404043 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:17404043 | lifeskim:mentions | umls-concept:C1515406 | lld:lifeskim |
pubmed-article:17404043 | lifeskim:mentions | umls-concept:C0918012 | lld:lifeskim |
pubmed-article:17404043 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:17404043 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:17404043 | lifeskim:mentions | umls-concept:C0442040 | lld:lifeskim |
pubmed-article:17404043 | pubmed:dateCreated | 2007-4-3 | lld:pubmed |
pubmed-article:17404043 | pubmed:abstractText | Growth factors and nitric oxide (NO) play a major role in dysregulated immune response in ulcerative colitis (UC). Recent evidence has shown increased levels of transforming growth factor-beta(1) (TGF-beta(1)) in UC and suggested an anti-inflammatory effect for this factor. Based on our recent study, dysfunctional immunoregulation is present in saliva of UC patients, we hypothesized that salivary level of NO and TGF-beta(1) may differ by severity of UC and be useful to determine the activity of the disease. Thirty-seven UC patients and 15 healthy controls were enrolled and saliva samples were obtained. Truelove-Witts severity index and modified Truelove-Witts severity index were used to determine the severity of the disease. NO and TGF-beta(1) levels were detected in saliva of all patients and control subjects using enzyme-linked immunosorbent assay. A total of 21 patients had mild disease while 8 had moderate and 8 had severe colitis. Adjusted for baseline characteristics, the levels of NO and TGF-beta(1) in different groups were compared. Salivary NO and TGF-beta(1) levels were higher in UC patients comparing to controls (P < 0.00005 and P = 0.005, respectively). The levels of NO and TGF-beta(1) showed no significant differences among the severity groups (P = 0.46 and P = 0.23, respectively). NO levels linearly increased by age (Coeff = 1.5, r = 0.38, P = 0.02). Gender, extension of disease, and medical treatment did not affect NO and TGF-beta(1) levels. Although UC patients have abnormal amounts of NO and TGF-beta(1) in their saliva, their disease activity cannot be predicted by these factors, which may indicate a pathophysiologic role rather than being nonspecific inflammatory markers for TGF-beta(1) and NO. | lld:pubmed |
pubmed-article:17404043 | pubmed:language | eng | lld:pubmed |
pubmed-article:17404043 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17404043 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17404043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17404043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17404043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17404043 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17404043 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17404043 | pubmed:month | Jan | lld:pubmed |
pubmed-article:17404043 | pubmed:issn | 0077-8923 | lld:pubmed |
pubmed-article:17404043 | pubmed:author | pubmed-author:AbdollahiMoha... | lld:pubmed |
pubmed-article:17404043 | pubmed:author | pubmed-author:NikfarShekouf... | lld:pubmed |
pubmed-article:17404043 | pubmed:author | pubmed-author:RezaieAliA | lld:pubmed |
pubmed-article:17404043 | pubmed:author | pubmed-author:DaryaniNaser... | lld:pubmed |
pubmed-article:17404043 | pubmed:author | pubmed-author:ZamaniMohamma... | lld:pubmed |
pubmed-article:17404043 | pubmed:author | pubmed-author:MohammadiradA... | lld:pubmed |
pubmed-article:17404043 | pubmed:author | pubmed-author:KhalajSaraS | lld:pubmed |
pubmed-article:17404043 | pubmed:author | pubmed-author:ShabihkhaniMa... | lld:pubmed |
pubmed-article:17404043 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17404043 | pubmed:volume | 1095 | lld:pubmed |
pubmed-article:17404043 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17404043 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17404043 | pubmed:pagination | 305-14 | lld:pubmed |
pubmed-article:17404043 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:17404043 | pubmed:meshHeading | pubmed-meshheading:17404043... | lld:pubmed |
pubmed-article:17404043 | pubmed:meshHeading | pubmed-meshheading:17404043... | lld:pubmed |
pubmed-article:17404043 | pubmed:meshHeading | pubmed-meshheading:17404043... | lld:pubmed |
pubmed-article:17404043 | pubmed:meshHeading | pubmed-meshheading:17404043... | lld:pubmed |
pubmed-article:17404043 | pubmed:meshHeading | pubmed-meshheading:17404043... | lld:pubmed |
pubmed-article:17404043 | pubmed:meshHeading | pubmed-meshheading:17404043... | lld:pubmed |
pubmed-article:17404043 | pubmed:meshHeading | pubmed-meshheading:17404043... | lld:pubmed |
pubmed-article:17404043 | pubmed:meshHeading | pubmed-meshheading:17404043... | lld:pubmed |
pubmed-article:17404043 | pubmed:meshHeading | pubmed-meshheading:17404043... | lld:pubmed |
pubmed-article:17404043 | pubmed:meshHeading | pubmed-meshheading:17404043... | lld:pubmed |
pubmed-article:17404043 | pubmed:meshHeading | pubmed-meshheading:17404043... | lld:pubmed |
pubmed-article:17404043 | pubmed:meshHeading | pubmed-meshheading:17404043... | lld:pubmed |
pubmed-article:17404043 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17404043 | pubmed:articleTitle | Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients. | lld:pubmed |
pubmed-article:17404043 | pubmed:affiliation | Department of Toxicology & Pharmacology, Faculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 14155-6451, Iran. | lld:pubmed |
pubmed-article:17404043 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17404043 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:7040 | entrezgene:pubmed | pubmed-article:17404043 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:17404043 | lld:entrezgene |
lhgdn:association:56026 | lhgdn:found_in | pubmed-article:17404043 | lld:lhgdn |